NDC 72266-160

ziprasidone mesylate

Ziprasidone Mesylate

ziprasidone mesylate is a Intramuscular Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Fosun Pharma Usa Inc.. The primary component is Ziprasidone Mesylate.

Product ID72266-160_a5b28ef8-706c-b9e9-e053-2995a90afdc4
NDC72266-160
Product TypeHuman Prescription Drug
Proprietary Nameziprasidone mesylate
Generic NameZiprasidone Mesylate
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2020-06-15
Marketing CategoryANDA / ANDA
Application NumberANDA211908
Labeler NameFosun Pharma USA Inc.
Substance NameZIPRASIDONE MESYLATE
Active Ingredient Strength20 mg/mL
Pharm ClassesAtypical Antipsychotic [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 72266-160-10

10 VIAL, SINGLE-DOSE in 1 CARTON (72266-160-10) > 1 mL in 1 VIAL, SINGLE-DOSE (72266-160-01)
Marketing Start Date2020-06-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "ziprasidone mesylate" or generic name "Ziprasidone Mesylate"

NDCBrand NameGeneric Name
43598-061ziprasidone mesylateziprasidone mesylate
43598-848ziprasidone mesylateziprasidone mesylate
51662-1564ZIPRASIDONE MESYLATEZIPRASIDONE MESYLATE
68083-340ziprasidone mesylateziprasidone mesylate
72205-205ziprasidone mesylateziprasidone mesylate
72266-160ziprasidone mesylateziprasidone mesylate
0049-1203Geodonziprasidone mesylate
0049-3920Geodonziprasidone mesylate
50090-4540Geodonziprasidone mesylate
64725-3920Geodonziprasidone mesylate

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.